211 related articles for article (PubMed ID: 33360223)
1. Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study.
Li S; Chen D; Xiu M; Li J; Zhang XY
J Psychiatr Res; 2021 Feb; 134():39-47. PubMed ID: 33360223
[TBL] [Abstract][Full Text] [Related]
2. Association of Brain-Derived Neurotrophic Factor With Cognitive Function: An Investigation of Sex Differences in Patients With Type 2 Diabetes.
Zhen YF; Liu XY; Li YK; Fang H; Cassidy RM; Zhang XY
Psychosom Med; 2019; 81(6):488-494. PubMed ID: 31083054
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia.
Qu M; Wang J; Chen DC; Chen S; Xiu MH; Zhang XY
Free Radic Biol Med; 2020 Nov; 160():887-893. PubMed ID: 32949664
[TBL] [Abstract][Full Text] [Related]
4. Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls.
Zhen YF; Liu XY; Zhou DH; Du X; Yin G; Zhang Y; Fang H; Xu G; Soares JC; Zhang XY
Oncotarget; 2018 Jan; 9(3):3653-3662. PubMed ID: 29423073
[TBL] [Abstract][Full Text] [Related]
5. Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.
Xiu MH; Li Z; Chen DC; Chen S; Curbo ME; Wu HE; Tong YS; Tan SP; Zhang XY
Schizophr Bull; 2020 Dec; 46(6):1498-1510. PubMed ID: 32390043
[TBL] [Abstract][Full Text] [Related]
6. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.
Zhen YF; Zhang J; Liu XY; Fang H; Tian LB; Zhou DH; Kosten TR; Zhang XY
Psychopharmacology (Berl); 2013 May; 227(1):93-100. PubMed ID: 23263460
[TBL] [Abstract][Full Text] [Related]
7. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
9. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
[No Abstract] [Full Text] [Related]
10. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
[No Abstract] [Full Text] [Related]
12. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
[TBL] [Abstract][Full Text] [Related]
13. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
14. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
15. Smoking affects the association between cognitive impairment and P50 inhibition defects in patients with chronic schizophrenia: A case-control study.
Wang DM; Xia LY; Zhou HX; Tian Y; Dai QL; Xiu MH; Chen DC; Wang L; Zhang XY
Asian J Psychiatr; 2023 Jan; 79():103391. PubMed ID: 36516649
[TBL] [Abstract][Full Text] [Related]
16. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum undercarboxylated osteocalcin is associated with cognitive impairment in male patients with type 2 diabetes.
Fang H; Xu XY; Xu RZ; Zhen YF; Xu G; Li YK
J Diabetes Complications; 2018 Jan; 32(1):56-60. PubMed ID: 29126874
[TBL] [Abstract][Full Text] [Related]
18. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
[TBL] [Abstract][Full Text] [Related]
19. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
[TBL] [Abstract][Full Text] [Related]
20. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]